Crypto Options at Crypto-Native Firms: Coinbase, OpenSea, Solana Labs

Coinbase went public in April 2021. OpenSea never did and remains a Delaware C-corp with a cap table, a 409A valuation, and a conventional ISO plan. Solana Labs is a Delaware C-corp whose token (SOL) is controlled by the Solana Foundation, a Swiss stiftung, which creates a separation between equity grants and token grants. Each firm’s employees face a different tax map.

This article walks through the options and RSU structures at three crypto-native firms, because the combinations are common across the industry and the tax traps repeat.

Coinbase: Post-IPO Stock Options and RSUs, Tokens Only as Trading Assets

Coinbase went public via direct listing on Nasdaq in April 2021. Its compensation structure is identical to any other public-company tech employer: incentive stock options (ISOs) capped by §422(d)‘s $100,000 first-year-exercisable limit, non-qualified stock options (NSOs) above that, and double-trigger RSUs that settle into COIN stock.

The complications at Coinbase are not in the equity comp itself. They are in the edge cases:

• Executive crypto holdings disclosed in proxy statements. Some Coinbase executives hold personal crypto positions disclosed under 10b5-1 plan requirements, with trading restricted during Coinbase’s blackout windows. Personal BTC or ETH trading by a Coinbase insider can run into Rule 10b5-1(c)(1) safe-harbor issues if the executive has material non-public information about Coinbase’s custody exposure to that asset.
• COIN stock compensation doesn’t qualify for §1202 QSBS because Coinbase was public when most employees received grants.
• No token compensation at Coinbase itself. The company does not have its own token. Employees receive zero tokens as comp. The grant is always stock.

Coinbase’s RSU structure follows post-IPO norms: quarterly vesting, supplemental withholding at 22%/37%, and a sell-to-cover mechanism with a designated broker. The blackout windows are structured around quarterly earnings, and insider trading plans use Rule 10b5-1(c)(1) with minimum 90-day cooling-off periods.

The common tax mistake at Coinbase: employees assume that because they work at a crypto company, crypto they buy on the side has some favorable treatment. It doesn’t. Personal BTC, ETH, or COIN trading is treated identically to any other taxpayer’s crypto trading. No §1202, no wash-sale exemption, no special rate.

OpenSea: Equity Plus Token, Two Separate Grants, Two Separate Vesting Schedules

OpenSea is a Delaware C-corp with a standard ISO/NSO/RSU plan and a separate token allocation held at the OpenSea DAO or a foundation entity. Employees often receive both: a conventional equity grant (say 40,000 RSUs over four years) and a token grant (say 300,000 OSEA tokens over four years with separate cliff).

Each grant is a separate tax event. The equity RSUs follow normal §83 treatment at each vest, with W-2 reporting from the Delaware C-corp and supplemental withholding. The token grant follows crypto compensation treatment under Notice 2014-21 and Rev. Rul. 2019-24, potentially with different employer entity reporting, different withholding, and different liquidity.

The mismatch creates planning friction:

• Different vesting dates. Equity vests on anniversary of hire. Tokens vest on a foundation-determined release schedule that may or may not align.
• Different withholding mechanics. Equity uses sell-to-cover. Tokens may not.
• Different §1202 eligibility. The equity grant, if held five years from when the stock was issued and the company qualified as a QSB, may qualify for 100% gain exclusion up to $10M or 10x basis. The token grant does not qualify.
• Different 83(b) windows. The equity grant may be early-exercisable with 83(b) availability on the exercise. The token grant may have 83(b) availability at token grant if the contract is structured as property transfer. Two separate 30-day windows, two separate elections, two separate filings.

An OpenSea employee who joins in 2025 with both grants should (1) file 83(b) on any early-exercised stock within 30 days, (2) analyze whether the token grant contract qualifies for 83(b) and file separately if so, (3) track both grants independently, and (4) coordinate selling across both to avoid cascading AMT and concentration exposure.

Without a coordinator (a crypto-literate CPA or family office), the typical outcome is that one side of the compensation gets managed and the other side creates a surprise April 15 bill.

Solana Labs: Equity in a Delaware C-Corp, Tokens Through a Swiss Foundation

Solana Labs is the for-profit Delaware C-corp that builds core Solana software. The Solana Foundation is a Swiss stiftung that holds and allocates SOL tokens. The two entities are separate. Employees at Solana Labs receive equity grants from the C-corp and token grants from the foundation, with different tax posture.

The equity grants from Solana Labs follow normal C-corp rules. Early employees received ISOs at low strike prices pre-2020, exercised, held five years, and qualify for §1202 QSBS treatment on sale. A founder who received $500,000 of stock in 2019 at a $1 FMV, held through 2024 with the company’s gross assets under $50M at issuance, and sold in 2025 can exclude up to the greater of $10M or 10x basis ($5M) from federal tax under §1202(b).

The token grants from the Solana Foundation create a different problem. Tokens vest on foundation-determined schedules. The foundation may or may not issue a U.S.-compatible tax form (foreign payors are not required to issue W-2s; Swiss foundations issue nothing to U.S. tax authorities). Employees self-report the income on Schedule 1 as “other income” or as wages depending on how the foundation classifies the arrangement.

A Solana Labs employee with both grants should: (1) treat the Delaware equity grant as conventional comp with §1202 analysis, (2) treat the Swiss foundation token grant as other income with manual reporting, (3) file an FBAR (Form 114) if total foreign account balances exceed $10,000 at any time during the year (the foundation-held token balance does not typically count because it is not an “account,” but any subsequent transfer to a foreign exchange does), and (4) expect to self-compute quarterly estimated tax because no withholding occurs on the token side.

The FBAR question is the one where employees most often fail. If you receive a foundation grant but the tokens sit in a foundation-controlled wallet until vest, FBAR does not apply to you during the lockup (no dominion, no reportable account). Once vested and transferred to your own wallet, FBAR still does not apply (self-custody is not an account). FBAR triggers if you then move tokens to a foreign exchange (Binance non-U.S., OKX) and hold balances there.

The General Pattern: Two-Grant Architecture

The three firms above illustrate a general pattern used across crypto-native companies: separate the equity grant (for the C-corp’s general enterprise value) from the token grant (for the protocol’s token economy). The employer can vary the mix based on role: core infrastructure engineers might get 70% equity / 30% tokens, while protocol-facing BD or community roles might get 20% equity / 80% tokens.

The tax-planning questions repeat across the industry:

1. Which grant qualifies for §1202? Only the equity grant, and only if the C-corp qualifies as a QSB and the holding period is met.
2. Which grant qualifies for 83(b)? Either, depending on structure. Equity 83(b) is available on early exercise of options or on restricted stock grants. Token 83(b) is available only if the token contract is §83 property.
3. Which grant creates QSBS stacking opportunities? Only the equity. §1202 stacking via non-grantor trusts applies only to C-corp stock.
4. Which grant creates AMT exposure? Only the equity, and only for ISOs under §55. Tokens are ordinary income at vest, fully in the regular income system.
5. Which grant creates §409A deferred-comp issues? Both can. Token release schedules that look like deferred compensation can trigger §409A’s 20% penalty if structured without a §409A-compliant election.

Frequently Asked

Do tokens count toward the $100,000 ISO limit under §422(d)? No. The ISO limit applies to options on employer stock. Tokens are a separate asset class.

Can I use my equity grant’s QSBS exclusion to offset gains on token sales? No. §1202 exclusion applies only to the gain on the QSBS-eligible stock. Gains on separate token sales are taxed independently.

What if my employer grants tokens through a foundation in a tax-haven jurisdiction? The compensation is still ordinary income to you under §61 regardless of where the payor is domiciled. You self-report if no W-2 or 1099 is issued. Report-source matters for audit posture, not for your underlying liability.

Can I structure a §1045 rollover on stock from a crypto-native firm? Yes, if the stock is QSBS. §1045 allows a 60-day rollover of QSBS gain into another QSBS-eligible company’s stock with deferral of recognition. Applies only to equity, not tokens.

Are there special rules for employees at stablecoin issuers (Circle, Tether, Paxos)? No. Stablecoin issuers are conventional C-corps with conventional comp structures. The token (USDC, USDT) is not a compensation asset for employees; it’s the company’s product.